Grove Bank & Trust’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$933K Sell
1,861
-20
-1% -$9.6K 0.09% 120
2026
Q1
$925K Buy
1,881
+98
+5% +$53.2K 0.1% 118
2025
Q4
$1.03M Buy
1,783
+503
+39% +$284K 0.12% 112
2025
Q3
$621K Sell
1,280
-4,693
-79% -$2.18M 0.07% 151
2025
Q2
$2.42M Sell
5,973
-317
-5% -$133K 0.3% 66
2025
Q1
$3.13M Buy
6,290
+132
+2% +$71.5K 0.42% 54
2024
Q4
$3.2M Buy
6,158
+66
+1% +$36.3K 0.44% 48
2024
Q3
$3.77M Buy
6,092
+187
+3% +$111K 0.56% 41
2024
Q2
$3.27M Buy
5,905
+250
+4% +$143K 0.52% 40
2024
Q1
$3.29M Buy
5,655
+2,107
+59% +$1.18M 0.55% 43
2023
Q4
$1.88M Buy
3,548
+70
+2% +$33.9K 0.35% 57
2023
Q3
$1.76M Buy
3,478
+316
+10% +$168K 0.36% 57
2023
Q2
$1.65M Buy
3,162
+91
+3% +$49.1K 0.33% 58
2023
Q1
$1.77M Buy
3,071
+37
+1% +$20.9K 0.37% 55
2022
Q4
$1.67M Buy
3,034
+1,813
+148% +$961K 0.37% 58
2022
Q3
$619K Hold
1,221
0.15% 116
2022
Q2
$663K Hold
1,221
0.16% 112
2022
Q1
$721K Buy
1,221
+93
+8% +$53.4K 0.14% 126
2021
Q4
$753K Hold
1,128
0.14% 124
2021
Q3
$644K Hold
1,128
0.14% 127
2021
Q2
$569K Sell
1,128
-4
-0.4% -$1.89K 0.12% 129
2021
Q1
$517K Sell
1,132
-7
-0.6% -$3.34K 0.12% 135
2020
Q4
$531K Buy
1,139
+159
+16% +$74.6K 0.14% 125
2020
Q3
$433K Buy
980
+93
+10% +$38.4K 0.13% 129
2020
Q2
$321K Buy
887
+94
+12% +$31.5K 0.11% 146
2020
Q1
$225K Sell
793
-349
-31% -$110K 0.09% 153
2019
Q4
$371K Sell
1,142
-5
-0.4% -$1.52K 0.11% 140
2019
Q3
$334K Buy
1,147
+306
+36% +$87.6K 0.11% 144
2019
Q2
$247K Buy
841
+26
+3% +$7.16K 0.09% 150
2019
Q1
$223K Buy
+815
New +$203K 0.09% 153
2018
Q1
Sell
-755
Closed -$143K 433
2017
Q4
$143K Sell
755
-345
-31% -$66.1K 0.06% 194
2017
Q3
$208K Buy
1,100
+240
+28% +$43.5K 0.1% 153
2017
Q2
$150K Buy
860
+143
+20% +$24K 0.1% 159
2017
Q1
$110K Sell
717
-950
-57% -$145K 0.09% 156
2016
Q4
$235K Buy
1,667
+72
+5% +$10.6K 0.18% 97
2016
Q3
$254K Buy
1,595
+600
+60% +$92.5K 0.22% 88
2016
Q2
$147K Hold
995
0.13% 105
2016
Q1
$141K Hold
995
0.13% 106
2015
Q4
$141K Buy
+995
New +$133K 0.13% 112

Other funds holding TMO

Grove Bank & Trust's TMO Position: Q2 2026 in Review

Grove Bank & Trust reduced its Thermo Fisher Scientific (TMO) stake by 1.1% in Q2 2026, selling an estimated $9.6K and leaving 1,861 shares worth $933K. The position accounts for 0.09% of the portfolio, ranked #120.

Grove Bank & Trust first reported a position in TMO in Q4 2015 and has held it in 39 quarters since. The position peaked at $3.77M in Q3 2024. 623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Grove Bank & Trust held 1,861 shares of Thermo Fisher Scientific worth $933K as of Q2 2026.
  • Grove Bank & Trust sold 20 Thermo Fisher Scientific shares in Q2 2026, an estimated $9.6K.
  • Thermo Fisher Scientific made up 0.09% of Grove Bank & Trust's portfolio in Q2 2026, its #120 holding.
  • Grove Bank & Trust first reported a position in Thermo Fisher Scientific in Q4 2015 and has held it in 39 quarters since.
  • Grove Bank & Trust's Thermo Fisher Scientific position peaked at $3.77M in Q3 2024.
  • 623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.